Yvette Bordelon, M.D., Ph.D.


Work Titles
UCLA Assistant Professor, Neurology
Education:
Degrees:
M.D., University of Pennsylvania School of Medicine, 1999
Ph.D.
Residency:
Massachusetts General and Brigham and Women's Hospitals Neurology Residency Program
Certifications:
Certifications:
American Board of Psychiatry and Neurology
2005 American Board of Psychiatry and Neurology

Contact Information:

Email Address:

ybordelon@mednet.ucla.edu


Website:

Web-Profile

Work Phone Number:

(310) 794-1195

310-206-2154

Office Address:

A-149 RNRC
710 Westwood Plaza
Los Angeles, CA 90095


Detailed Biography:

Dr. Bordelon received her MD and PhD degrees from the University of Pennsylvania. Her thesis work was performed with Dr. Marie-Francoise Chesselet and involved investigating mechanisms of cell death in an animal model of Huntington disease. She went on to residency training at Massachusetts General and Brigham and Women���s Hospitals and then did a Movement Disorders Fellowship at Columbia University before joining the Neurology faculty at UCLA in 2004. Her clinical work involves the diagnosis and treatment of Movement Disorders and her clinical research interests include clinical trials and development of biomarkers of disease in this subspecialty.

Publications:

  Add here . . , , ; .
O'Duffy, A. E. Bordelon, Y. M. McLaughlin, B.   Killer proteases and little strokes--how the things that do not kill you make you stronger J Cereb Blood Flow Metab, 2007; 27(4): 655-68.
Bartzokis, G Lu, PH Tishler, TA Fong, SM Oluwadara, B Finn, JP Huang, D Bordelon, Y Mintz, J Perlman, S   Myelin Breakdown and Iron Changes in Huntington's Disease: Pathogenesis and Treatment Implications Neurochem Res, 2007; .
Frucht, SJ Houghton, WC Bordelon, Y Greene, PE Louis, ED   A single-blind, open-label trial of sodium oxybate for myoclonus and essential tremor Neurology, 2005; 65(12): 1967-9.
Frucht, SJ Bordelon, Y Houghton, WH Reardan, D   A pilot tolerability and efficacy trial of sodium oxybate in ethanol-responsive movement disorders Movement disorders : official journal of the Movement Disorder Society, 2005; 20(10): 1330-7.
Frucht, SJ Bordelon, Y Houghton, WH   Marked amelioration of alcohol-responsive posthypoxic myoclonus by gamma-hydroxybutyric acid (Xyrem) Movement disorders : official journal of the Movement Disorder Society, 2005; 20(6): 745-51.
Bordelon, YM Mackenzie, L Chesselet, MF   Morphology and compartmental location of cells exhibiting DNA damage after quinolinic acid injections into rat striatum The Journal of comparative neurology, 1999; 412(1): 38-50.
Bordelon, YM Chesselet, MF Ereci????ska, M Silver, IA   Effects of intrastriatal injection of quinolinic acid on electrical activity and extracellular ion concentrations in rat striatum in vivo Neuroscience, 1998; 83(2): 459-69.
Bordelon, YM Chesselet, MF Nelson, D Welsh, F Erecinska, M   Energetic dysfunction in quinolinic acid-lesioned rat striatum Journal of neurochemistry, 1997; 69(4): 1629-39.
Gurevich, EV Bordelon, Y Shapiro, RM Arnold, SE Gur, RE Joyce, JN   Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study Archives of general psychiatry, 1997; 54(3): 225-32.

Does this profile need updating? Contact Us